Exploratory Study on POL6326 in Stem Cell Mobilization

NCT01105403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: POL6326

Sponsor

Polyphor Ltd.